Hongsik Kim

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Small Cell Lung Cancer

Top Venues

Therapeutic advances in medical oncology

Technology in cancer research & treatment

Therapeutic advances in gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Minkwan Cho, Eunkyung Park, Yong-Pyo Lee, Hongsik Kim, Hee Sue Park, Hee Kyung Kim, Yaewon Yang, Jihyun Kwon, Ki Hyeong Lee, Hye Sook Han
Efficacy of ferric carboxymaltose or darbepoetin alfa for chemotherapy-induced anemia in patients with esophagogastric or pancreaticobiliary cancer: a retrospective comparative study. Therapeutic advances in medical oncology 16 (2024)
Minkwan Cho, Eunkyung Park, Yong-Pyo Lee, Hongsik Kim, Hee Sue Park, Hee Kyung Kim, Yaewon Yang, Jihyun Kwon, Ki Hyeong Lee, Hye Sook Han
Efficacy of ferric carboxymaltose or darbepoetin alfa for chemotherapy-induced anemia in patients with esophagogastric or pancreaticobiliary cancer: a retrospective comparative study. Therapeutic advances in medical oncology 16 (2024)
Hongsik Kim, Ryul Kim, Hyunji Jo, Hye Ryeon Kim, Joohyun Hong, Sang Yun Ha, Joon Oh Park, Seung Tae Kim
Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer. Therapeutic advances in gastroenterology 15 (2022)
Hongsik Kim, Hana Kim, Ryul Kim, Hyunji Jo, Hye Ryeon Kim, Joohyun Hong, Joon Oh Park, Young Suk Park, Seung Tae Kim
Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer. Technology in cancer research & treatment 20 (2022)
Hongsik Kim, Dong-Wan Kim, Miso Kim, Young Joo Lee, Hee Kyung Ahn, Jang Ho Cho, Il Hwan Kim, Yun-Gyoo Lee, Seong-Hoon Shin, Song Ee Park, Jiyoon Jung, Eun Joo Kang, Myung-Ju Ahn
Long-term outcomes in patients with advanced and/or metastatic non-small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real-world data (KCSG LU20-11). Cancer (2021)